Jefferies reiterated coverage on Teladoc with a new price target
$TDOC
Medical/Nursing Services
Health Care
Jefferies reiterated coverage of Teladoc with a rating of Hold and set a new price target of $10.00 from $8.00 previously
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 3/10/2026 | $11.00 | Hold → Buy | Deutsche Bank |
| 2/26/2026 | $7.00 | Neutral → Buy | BofA Securities |
| 12/9/2025 | $8.50 | Equal Weight | Barclays |
| 11/13/2025 | $8.00 | Market Perform | BMO Capital Markets |
| 7/25/2025 | $10.00 | Neutral | Mizuho |
| 11/15/2024 | $14.00 | Buy | Goldman |
| 9/17/2024 | $8.00 → $10.00 | Hold | Jefferies |
| 2/29/2024 | $22.00 | Overweight | Cantor Fitzgerald |
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release second quarter 2026 results on Wednesday, July 29, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day. Conference Call Details The conference call can be accessed by dialing 833-461-5787 for U.S. participants and using the meeting ID # 478 236 923. For international participants, please visit the following link for global dial-in numbers, using the same meeting ID # 478 236 923: https://help.events.q4inc.com/eahc/international-dial-in-numbers. A live audio webca
NEW YORK, July 03, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee. Effective July 1, 2026, in connection with commencing employment as Head of Product of BetterHelp, David Packles was granted an award of restricted stock units covering 50,000 shares of Teladoc Health’s common stock, par value $0.001 per share ("Common Stock"). The restricted stock units vest, based on continued service to Teladoc Health, as to one-third of the underlying shares on the first anniversary of the grant date, with the remainder vesting quarterly over two years thereafter. The award was approved b
Veteran enterprise sales executive brings decades of experience scaling companies and leading successful commercial organizationsSURPRISE, Ariz., June 29, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in fertility control solutions for managing rodent populations, today announced the appointment of Jack Karabees as Executive Vice President of Sales. Mr. Karabees brings more than three decades of experience building and leading professional B2B sales organizations and helping companies define the processes and systems necessary to achieve significant scale. In his
144 - Teladoc Health, Inc. (0001477449) (Subject)
144 - Teladoc Health, Inc. (0001477449) (Subject)
144 - Teladoc Health, Inc. (0001477449) (Subject)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
4 - Teladoc Health, Inc. (0001477449) (Issuer)
Deutsche Bank upgraded Teladoc from Hold to Buy and set a new price target of $11.00
BofA Securities upgraded Teladoc from Neutral to Buy and set a new price target of $7.00
Barclays initiated coverage of Teladoc with a rating of Equal Weight and set a new price target of $8.50
Veteran enterprise sales executive brings decades of experience scaling companies and leading successful commercial organizationsSURPRISE, Ariz., June 29, 2026 /PRNewswire/ -- SenesTech, Inc. (NASDAQ:SNES), a leader in fertility control solutions for managing rodent populations, today announced the appointment of Jack Karabees as Executive Vice President of Sales. Mr. Karabees brings more than three decades of experience building and leading professional B2B sales organizations and helping companies define the processes and systems necessary to achieve significant scale. In his
NEW YORK, March 30, 2026 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE:TDOC), the global leader in virtual care, today announced the appointment of Susan Salka to its board of directors, effective immediately. Ms. Salka is the former president and CEO of AMN Healthcare Services, a provider of healthcare workforce technology solutions and staffing services to healthcare facilities across the US. She joins following the retirements of Eric Evans and Thomas McKinley and the appointment of Michael Smith. She will serve on the board's audit and compensation committees. "Susan brings a powerful combination of healthcare leadership and governance experience to the Board," said Kenneth H. Paulus, non‑
NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- MarketNewsUpdates News Commentary A recent report from ResearchAndMarkets said that the U.S. augmented reality and virtual reality in healthcare market size which was estimated at USD 1.03 billion in 2024 is projected to grow at a CAGR of 15.4% from 2025 to 2030. It said that advancements in healthcare IT infrastructure and increased venture capital investment, fueled by numerous start-ups and government programs such as NIH and FDA initiatives, support AR/VR research. In addition, the declining cost of head-mounted devices, rising demand from telemedicine, chronic disease care, and minimally invasive surgery, and integration with AI and 5G tech
NEW YORK, July 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release second quarter 2026 results on Wednesday, July 29, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day. Conference Call Details The conference call can be accessed by dialing 833-461-5787 for U.S. participants and using the meeting ID # 478 236 923. For international participants, please visit the following link for global dial-in numbers, using the same meeting ID # 478 236 923: https://help.events.q4inc.com/eahc/international-dial-in-numbers. A live audio webca
NEW YORK, April 29, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today reported financial results for the three months ended March 31, 2026 ("First Quarter 2026"). Unless otherwise noted, percentage and other changes are relative to the three months ended March 31, 2025 ("First Quarter 2025"). Highlights First Quarter 2026 revenue of $613.8 million, down 2% year-over-yearFirst Quarter 2026 net loss of $63.8 million, or $0.36 per shareFirst Quarter 2026 adjusted EBITDA of $58.2 million, essentially flat year-over-yearIntegrated Care segment revenue of $395.4 million, up 2% year-over-year, and adjusted EBITDA margin of 14.2%BetterHelp segmen
NEW YORK, April 15, 2026 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE:TDOC), the global leader in virtual care, announced that it will release first quarter 2026 results on Wednesday, April 29, 2026, after the market closes. In conjunction, the company will host a conference call to review results at 5:00 p.m. ET on the same day. Conference Call Details The conference call can be accessed by dialing (800) 715-9871 for U.S. participants and using the conference ID # 2214924. For international participants, please visit the following link for global dial-in numbers, using the same conference ID # 2214924: https://registrations.events/directory/international/itfs.html. A live audio webca
SC 13G - Teladoc Health, Inc. (0001477449) (Subject)
SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)
SC 13G/A - Teladoc Health, Inc. (0001477449) (Subject)